DIAPH3 is a multifaceted prognostic biomarker that links immunotherapy response to tumor microenvironment in prostate cancer.

Discov Oncol · 2026 · PMC12891325 · PMID 41545793

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

did not reach statistical significanceP = 0.17not close (p > 0.1)

In this PCa-specific analysis, the association between DIAPH3 expression and overall survival after immunotherapy did not reach statistical significance (HR = 1.32, 95% CI: 0.89–1.96, log-rank P = 0.17).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.